AXIOS (Tina Reed) - Medicare weight-loss drug coverage could overwhelm doctors
Next month's launch of a Medicare program providing weight-loss drugs for $50 a month is expected to unleash pent-up demand for Wegovy, Zepbound and other blockbuster treatments — and create new bottlenecks at doctors' offices. The big picture: It could become one of the biggest drug rollouts ever — and it could test an already burdened system as seniors seek new GLP-1 prescriptions. - Clinicians worry that could also give short shrift to patient counseling on how to take the injectables and pills, adjust dosages and deal with side effects. - Medicare has been prohibited by law from covering weight-loss drugs. Where it stands: The new program is part of a deal President Trump struck with Eli Lilly and Novo Nordisk to cut prices for…